Insulin resistance and cardiovascular disease
Journal of International Medical Research · 2023-03 · 51 (3)
DOI: 10.1177/03000605231164548 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of International Medical Research, online erschienen am 30.03.2023. Verfasst von Constantine E Kosmas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Cardiovascular Diseases, Hypertension. Die Arbeit wurde bisher 396-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Insulin resistance (IR) and cardiovascular disease (CVD) represent two universal public health hazards, especially in today’s Western societies. A causal-effect relationship has been established that links IR with CVD. The mediating mechanisms are perplexing, under ongoing, rigorous investigation and remain to be fully elucidated. IR is a condition encompassing hyperglycemia and compensatory hyperinsulinemia. It occurs when insulin is not capable of exerting its maximum effects on target tissues, including skeletal muscles, liver and adipose tissue. This alteration of insulin signaling pathways results in the development of cardiometabolic disorders, including obesity, dyslipidemia, low-grade inflammation, endothelial dysfunction and hypertension, all of which are predisposing factors for atherosclerosis and CVD. The management of IR can be achieved through dietary modifications, the inclusion of regular exercise routines in everyday life, pharmacological agents and other interventions tailored to each individual patient’s needs. It is important to underline though that, although various antidiabetic drugs that may improve IR are available, no medications are as yet specifically approved for the treatment of IR. This narrative review will focus on the current scientific and clinical evidence pertaining to IR, the mechanisms connecting IR with CVD, as well as plausible strategies for a holistic, personalized approach for IR management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.
- School of Medicine, University of Crete, Heraklion, Greece.
- Laboratory of Clinical Chemistry, Medical Department, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
- General Directorate of Public Health and Social Welfare, Attica Region, Athens, Greece.
- Athens Bioclinic, Athens, Greece.
ORCID-Profile: Constantine E Kosmas, Christina E Kostara
Zitieren
APA
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023). Insulin resistance and cardiovascular disease. Journal of International Medical Research, 51(3). https://doi.org/10.1177/03000605231164548
Vancouver
Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. Journal of International Medical Research. 2023;51(3). doi:10.1177/03000605231164548
BibTeX
@article{Kosmas2023,
author = {Kosmas, Constantine E and Bousvarou, Maria D and Kostara, Christina E and Papakonstantinou, Evangelia J and Salamou, Evdokia and Guzman, Eliscer},
title = {Insulin resistance and cardiovascular disease},
journal = {Journal of International Medical Research},
year = {2023},
volume = {51},
number = {3},
doi = {10.1177/03000605231164548}
}
EUVIMED